WOLFGANG WINKELMAYER to Costs and Cost Analysis
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Costs and Cost Analysis.
Connection Strength
0.146
-
Associations between demographic factors and provider structures on cost and length of stay for hemodialysis patients with vascular access failure. Clin J Am Soc Nephrol. 2006 May; 1(3):455-61.
Score: 0.063
-
A Cost Analysis of Tolerance Induction for Two-Haplotype Match Kidney Transplant Recipients. Am J Transplant. 2016 Jan; 16(1):371-3.
Score: 0.030
-
Potential savings in prescription drug costs for hypertension, hyperlipidemia, and diabetes mellitus by equivalent drug substitution in Austria: a nationwide cohort study. Appl Health Econ Health Policy. 2015 Apr; 13(2):193-205.
Score: 0.029
-
The prevalence and cost of unapproved uses of top-selling orphan drugs. PLoS One. 2012; 7(2):e31894.
Score: 0.023